---
figid: PMC7840025__pone.0245664.g001
figtitle: Association of a novel endometrial cancer biomarker panel with prognostic
  risk, platinum insensitivity, and targetable therapeutic options
organisms:
- Homo sapiens
pmcid: PMC7840025
filename: pone.0245664.g001.jpg
figlink: pmc/articles/PMC7840025/figure/pone.0245664.g001/
number: F1
caption: A, Integrated schematic of the TP53-p21-CDE/CHR and PIK3CA-AKT-FBW7 pathways
  in EC. B, Comparative analysis of the mRNA expression of oncogenes regulated directly
  or indirectly by the TP53-p21-CDE/CHR pathway in TP53 mutant (mu) (n = 62) vs wild
  type (wt) EC (n = 149) (excluding POLE mutants). C, Correlation coefficient analysis
  delineating relationships between differentially expressed oncogenes in TP53-mu
  (n = 62) and wt EC (n = 149) (excluding POLE mutants) as a function of mRNA expression
  of E2F1 and CCNA2 oncogenes. CDE indicates cell-cycle–dependent element; CHR, cell-cycle
  genes homology region; EC, endometrial cancer; wt, wild type.
papertitle: Association of a novel endometrial cancer biomarker panel with prognostic
  risk, platinum insensitivity, and targetable therapeutic options.
reftext: Jesus Gonzalez Bosquet, et al. PLoS One. 2021;16(1):e0245664.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5501148
figid_alias: PMC7840025__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7840025__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7840025__pone.0245664.g001.html
  '@type': Dataset
  description: A, Integrated schematic of the TP53-p21-CDE/CHR and PIK3CA-AKT-FBW7
    pathways in EC. B, Comparative analysis of the mRNA expression of oncogenes regulated
    directly or indirectly by the TP53-p21-CDE/CHR pathway in TP53 mutant (mu) (n
    = 62) vs wild type (wt) EC (n = 149) (excluding POLE mutants). C, Correlation
    coefficient analysis delineating relationships between differentially expressed
    oncogenes in TP53-mu (n = 62) and wt EC (n = 149) (excluding POLE mutants) as
    a function of mRNA expression of E2F1 and CCNA2 oncogenes. CDE indicates cell-cycle–dependent
    element; CHR, cell-cycle genes homology region; EC, endometrial cancer; wt, wild
    type.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R1
  - PIK3CA
  - CCNE1
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PIK3IP1
  - TP53
  - E2F1
  - UBE2L3
  - CCNA2
  - PTEN
  - EZH2
  - MASTL
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - AURKA
  - TPX2
  - PTPA
  - ESPL1
  - CIP2A
  - PLK1
  - RAD21
  - SMC3
  - TP73
  - ARHGAP24
  - GSK3B
  - FOXM1
  - FBXW7
  - MYC
  - BRCA2
  - SKP2
  - UXT
  - BRIP1
  - MRPL36
  - EXO1
  - RAD51
  - BRCA1
  - CDPF1
  - RRAD
  - MRE11
  - RAD50
  - NBN
  - NLRP2
  - SD
---
